Every few years, international groups of researchers revise the guidelines clinicians use to treat conditions like OCD. This paper is one of those revisions. It is the third version of a guideline from the World Federation of Societies of Biological Psychiatry, first published in 2002 and revised in 2008, and this edition addresses medication treatment for OCD and PTSD.
Guidelines matter because the research does not stand still. As evidence accumulates about what helps and what does not, the advice clinicians rely on needs to keep pace. An updated, evidence-based guideline allows prescribers to make better-informed decisions with their patients rather than working from material that is a decade old.
These particular guidelines concern pharmacological treatment, which is prescribed and managed by psychiatrists and GPs rather than psychologists. Medication and psychological therapy often work well alongside one another for OCD, so understanding the options is useful whichever path you are on.
If you are struggling with OCD, a registered psychologist or your GP can help you work out what support suits your situation.
What the guideline actually is
This paper is a clinical practice guideline rather than a single experiment. A task force from the World Federation of Societies of Biological Psychiatry assembled a consensus panel of 34 experts from 22 countries and asked what actually works across all the published randomised controlled trials on OCD and PTSD. A randomised controlled trial assigns people at random to a treatment or a comparison condition, which helps rule out other explanations for improvement. This is the third version of the guideline, following those of 2002 and 2008, and it is the first to rate psychotherapies and other non-drug treatments using the same strict standards normally applied to medications. Part II, covered here, draws on trials involving 291 people with OCD.
What it found for OCD
The panel rated selective serotonin reuptake inhibitors, a class of antidepressant that increases serotonin availability in the brain, and cognitive behavioural therapy as first-line treatments. First-line means they carry the strongest evidence and are recommended first. CBT for OCD generally centres on exposure and response prevention, gradually facing feared situations while resisting compulsions, though the abstract does not detail specific techniques. Internet-delivered CBT was found more effective than active control conditions, meaning comparison treatments designed to account for factors such as attention and expectation. That suggests remote delivery can be a genuine option rather than a lesser substitute.
For people who do not respond sufficiently to first-line options, the guideline lists second-line medications including clomipramine, an older antidepressant. For treatment-resistant OCD it describes augmentation, where a second medication such as an antipsychotic is added alongside an SSRI rather than replacing it. Newer non-drug approaches were also reviewed: repetitive transcranial magnetic stimulation, which uses magnetic pulses to stimulate particular brain regions, and deep brain stimulation, a more invasive option involving implanted electrodes and reserved for severe, otherwise unresponsive cases.
Why this matters
Guidelines exist to keep treatment decisions from resting on habit, opinion or outdated training. By weighing trial evidence systematically and reaching international consensus, they give clinicians a clear order of preference: begin with the best-supported options, and follow a structured plan if those prove insufficient. CBT and SSRIs are both rated first-line rather than one being cast as a fallback for the other, which reflects genuine evidence that psychological and pharmacological approaches can each help independently and can often be combined.
Its limits
A guideline is only as good as the trials it summarises. The abstract does not specify how many separate studies made up the pool of 291 OCD participants, nor the effect sizes involved. It also cannot say which treatment suits which person, which remains an individual clinical decision. The document reflects evidence and expert consensus up to publication, making it a snapshot rather than a final word.
If OCD is affecting your life, a registered psychologist or your GP can help you work through what support might suit you.